Horizon Therapeutics PLC (HZNP) stock is higher by 35.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives HZNP stock a score of 72 out of a possible 100. That rank is mainly influenced by a long-term technical score of 77. HZNP's rank also includes a short-term technical score of 71. The fundamental score for HZNP is 68. In addition to the average rating from Wall Street analysts, HZNP stock has a mean target price of $131.30. This means analysts expect the stock to increase 23.16% over the next 12 months.
News Home
Is Horizon Therapeutics PLC (HZNP) Stock Worth a Buy Wednesday?
Mentioned in this article
HZNP has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on HZNP!